MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Beispiel Observation: PatientKimMusterperson-MolecularPathologyObservation-3-WT1

German

Profile: MII PR MTB Immunohistochemistry version: 2027.0.0-ballot.1

status: Final

category: Laboratory, A characterization of a given biomarker observation.

code: Observation using immunohistochemistry (observable entity)

subject: Kim Musterperson (no stated gender), DoB: 1956-03-14

value: Tumorzellen durchgehend nukleär für WT1

bodySite: Nukleär

specimen: Specimen: accessionIdentifier = Z230201/23; type = Ascitic fluid specimen (specimen)

Components

-CodeValue[x]
*Gene studied [ID]WT1